We are an affiliate: if you order from Growth Guys using this code we earn a commission, at no extra cost to you. We are not Growth Guys and have no ownership of or role in the company.
This compound has been through large, long, registered trials with tens of thousands of participants, published in major journals, followed by years of post-market observation across millions of people.
This compound has been through large, long, registered trials with tens of thousands of participants, published in major journals, followed by years of post-market observation across millions of people. In this index that is exceptional rather than typical.
The practical value of listing it alongside the rest is contrast. When a summary says a compound is 'well researched', the question is whether it means this — registered phase three trials and a post-market record — or a dozen rodent papers. Both get described the same way.
What regulators approved is a specific manufacturer's formulation at defined doses. Material of the same molecule from a research supplier is outside that, and the published safety record does not transfer to it. This is the single most common error made about this compound.
More, not less. Where a licensed equivalent exists, the entire difference is provenance and composition — exactly what an independent report addresses.
Set it beside the trial-stage molecules in this index. Same class in some cases, same supply route, and an evidence base that is not remotely comparable. A purity figure says nothing about which side of that line a compound sits on.
The published set we counted contains 5 report(s) naming semaglutide, averaging 99.43% purity. Each resolves on the testing laboratory's own portal rather than as a file hosted by the seller.
Unlike most compounds in this category, this one has been through full regulatory assessment with published trial data and ongoing safety monitoring. That changes what can be said about it and what the appropriate sources are.
An extensive evidence base includes documented harms and contraindications that thinner literatures simply do not contain. More evidence means more known risks, and a shorter risk list elsewhere usually reflects less study rather than greater safety.
The claims on this page about the most heavily evidenced molecule in this index, which makes it the best illustration of what the others lack can be checked against sources outside this site: